Thursday, January 1, 2026 1/1/2026

Maternal-infant transfer of microbial modified immunity

Award Number: R21AI182934
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/01/2024
PERIOD OF PERFORMANCE END DATE: 01/31/2027

Group Awards By:

View Award Description

Maternal-infant transfer of microbial modified immunity - PROJECT SUMMARY/ABSTRACT Maternal leukocytes can migrate to an infant not only during pregnancy via the placenta, but also after delivery via breastfeeding. Immune cells in the milk have a significant heterogeneity, and they include innate cells [macrophages, neutrophils, natural killer cells] and adaptive [T and B] cells. The immature adaptive immune system needs education by the mother to facilitate immune tolerance and responsivity. A specific probiotic (Limosilactobacillus reuteri DSM 17938) has been examined in our laboratory and found to have anti-inflammatory effects in several disease models, including neonatal necrotizing enterocolitis (NEC), Treg-deficiency-induced autoimmunity (IPEX syndrome in humans), and in a mouse model of multiple sclerosis. Recently, we found that orally feeding DSM 17938 could modify the function of circulating Tregs. When probiotic- educated Tregs were adoptively transferred to newborn pups exposed to experimental NEC, probiotic-educated Tregs were more potent than naïve Treg cells at reducing inflammatory T cells. A current knowledge gap our understanding of how probiotics modify microbes, interact with leukocytes, and express metabolites that may be transferred from mother to infant to benefit early life immunity. The specific aims are to (1) characterize probiotic-modulated immune transfer from mother to infant. We will use mice with congenic markers to distinguish immune cells arising from mother and infant. We will gavage feed DSM 17938 to pregnant and lactating dam to identify the transfer of immunity from mother to infant via (via the placenta or breast milk) by studies of the cross-fostered newborn pups; and we will (2) assess the potentially beneficial effect of transferring probiotic-modulated immunity from mother to infant in the setting of Treg- deficiency-induced autoimmunity. In both aims, dynamic changes of stool microbiome and metagenome and plasma probiotic-modulated metabolites in the mother and infant will be determined.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON	7000 FANNIN ST FL 9	HOUSTON	TX	77030	HARRIS	USA	Allergy and Infectious Diseases Research	000	2	12/17/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $189,150 )
2025	2025	UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON	7000 FANNIN ST FL 9	HOUSTON	TX	77030	HARRIS	USA	Allergy and Infectious Diseases Research	000	2	1/17/2025	NON-COMPETING CONTINUATION	$189,150
														Subtotal = $189,150

Issue Date FY: 2024 ( Subtotal = $234,000 )
2024	2024	UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON	7000 FANNIN ST FL 9	HOUSTON	TX	77030	HARRIS	USA	Allergy and Infectious Diseases Research	001	1	9/12/2024	NEW	$23,400
2024	2024	UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON	7000 FANNIN ST FL 9	HOUSTON	TX	77030	HARRIS	USA	Allergy and Infectious Diseases Research	000	1	3/1/2024	NEW	$210,600
														Subtotal = $234,000

Grand Total All Awards = $423,150

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Maternal-infant transfer of microbial modified immunity

Award Number: R21AI182934

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/01/2024

PERIOD OF PERFORMANCE END DATE: 01/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer